Viewing Study NCT04952168


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-02-25 @ 8:27 PM
Study NCT ID: NCT04952168
Status: UNKNOWN
Last Update Posted: 2021-07-07
First Post: 2021-06-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
Sponsor: Yuan Chen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC, Stage III View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Almonertinib View
None chemoradiotherapy View